Highly-rated U.S. bond funds and exchange-traded funds logged inflows of $8.83 billion in the past week, the most in a week since January, according to BofA Global. That was up from inflows of $0.39 ...
Siren Biotechnology Inc. has unveiled its lead asset, SRN-101, for the treatment of high-grade gliomas. The FDA has granted orphan drug and rare pediatric disease designations to SRN-101 for ...